538 related articles for article (PubMed ID: 23760589)
1. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
3. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
4. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
5. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP
Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
9. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.
Mathews P; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Lyu H; Jaffee E; Zheng L; Yu E; Lee YJ
Ann Surg Oncol; 2013 Apr; 20(4):1216-22. PubMed ID: 23104706
[TBL] [Abstract][Full Text] [Related]
10. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.
Xia F; Lai EC; Lau WY; Ma K; Li X; Bie P; Qian C
Ann Surg Oncol; 2012 Apr; 19(4):1284-91. PubMed ID: 21913016
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
Wu JC; Huang YH; Chau GY; Su CW; Lai CR; Lee PC; Huo TI; Sheen IJ; Lee SD; Lui WY
J Hepatol; 2009 Nov; 51(5):890-7. PubMed ID: 19747749
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
[TBL] [Abstract][Full Text] [Related]
13. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
Jang JW; Choi JY; Bae SH; Yoon SK; Woo HY; Chang UI; Kim CW; Nam SW; Cho SH; Yang JM; Lee CD
Cancer; 2007 Oct; 110(8):1760-7. PubMed ID: 17724708
[TBL] [Abstract][Full Text] [Related]
14. Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients.
Wang Q; Fiel MI; Luan W; Blank S; Kadri H; Kim KW; Hiotis SP
Ann Surg Oncol; 2013 Nov; 20(12):3761-70. PubMed ID: 23771248
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
16. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation].
Li MR; Yi SH; Cai CJ; Yi HM; An YL; Wei M; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):271-4. PubMed ID: 21586225
[TBL] [Abstract][Full Text] [Related]
18. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
Viganò M; Bhoori S; Lampertico P; Donato MF; Iavarone M; Grossi G; Facciorusso A; Caccamo L; Rossi G; Colombo M; Mazzaferro V
Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
[TBL] [Abstract][Full Text] [Related]
19. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
